• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden.

作者信息

Jendle J, Buompensiere M I, Holm A L, de Portu S, Malkin S J P, Cohen O

机构信息

Institute of Medical Sciences, Örebro University, Campus USÖ, 701 82, Örebro, Sweden.

Medtronic International Trading Sàrl, Tolechenaz, Switzerland.

出版信息

Diabetes Ther. 2022 May;13(5):1125-1129. doi: 10.1007/s13300-022-01252-w. Epub 2022 Apr 11.

DOI:10.1007/s13300-022-01252-w
PMID:35403952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9076762/
Abstract
摘要

相似文献

1
A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden.对《致编辑的信：关于1型糖尿病患者使用先进混合闭环系统的成本效益：瑞典的一项健康经济分析》的回应
Diabetes Ther. 2022 May;13(5):1125-1129. doi: 10.1007/s13300-022-01252-w. Epub 2022 Apr 11.
2
The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: a Health Economic Analysis in Sweden.一种先进的混合闭环系统在1型糖尿病患者中的成本效益：瑞典的一项卫生经济分析
Diabetes Ther. 2021 Nov;12(11):2977-2991. doi: 10.1007/s13300-021-01157-0. Epub 2021 Oct 1.
3
Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.对《致编辑的信》的回应：关于荷兰1型糖尿病中混合闭环系统与多次每日注射加间歇性扫描式连续血糖监测的成本效益
Adv Ther. 2023 May;40(5):2545-2548. doi: 10.1007/s12325-023-02431-2. Epub 2023 Mar 9.
4
Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.美敦力 670G 混合闭环系统与持续皮下胰岛素输注治疗 1 型糖尿病的成本效益分析。
Diabetes Technol Ther. 2019 Mar;21(3):110-118. doi: 10.1089/dia.2018.0328. Epub 2019 Feb 20.
5
Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults with Type 1 Diabetes.1 型糖尿病成人患者闭环式混合系统与多次每日注射和毛细血管血糖检测的成本效果分析。
Diabetes Technol Ther. 2020 Nov;22(11):812-821. doi: 10.1089/dia.2020.0064. Epub 2020 Oct 19.
6
Letter to the Editor Regarding Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently-Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.致编辑的信：关于荷兰1型糖尿病患者中混合闭环系统与多次每日注射加间歇性扫描式连续血糖监测的成本效益比较
Adv Ther. 2023 May;40(5):2542-2544. doi: 10.1007/s12325-023-02427-y. Epub 2023 Mar 9.
7
Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.1型糖尿病中间歇性扫描式连续血糖监测与先进混合闭环系统的成本效益：对Jendle等人研究的评论
Diabetes Ther. 2022 May;13(5):1121-1123. doi: 10.1007/s13300-022-01251-x. Epub 2022 Apr 11.
8
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial.两种混合闭环系统在青少年和年轻成人 1 型糖尿病患者中的比较（FLAIR）：一项多中心、随机、交叉试验。
Lancet. 2021 Jan 16;397(10270):208-219. doi: 10.1016/S0140-6736(20)32514-9.
9
Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece.希腊1型糖尿病患者使用先进混合闭环胰岛素输送系统的成本效益分析。
Diabetes Technol Ther. 2022 May;24(5):316-323. doi: 10.1089/dia.2021.0443.
10
The Cost-Effectiveness of an Advanced Hybrid Closed-Loop System Compared to Standard Management of Type 1 Diabetes in a Singapore Setting.在新加坡环境下，一种先进的混合闭环系统与 1 型糖尿病标准管理相比的成本效益。
Diabetes Technol Ther. 2024 May;26(5):324-334. doi: 10.1089/dia.2023.0455. Epub 2024 Mar 22.

引用本文的文献

1
Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross-sectional study using data from the Canadian T1D (BETTER) Registry.魁北克1型糖尿病成年人的社会劣势与技术使用情况：一项使用加拿大1型糖尿病（BETTER）登记处数据的横断面研究。
Diabetes Obes Metab. 2025 Jul;27(7):3921-3932. doi: 10.1111/dom.16426. Epub 2025 Apr 29.
2
Response to: Letter to the Editor with Regard to the Cost-Effectiveness of Hybrid Closed-Loop Systems Versus Multiple Daily Injections Plus Intermittently Scanned Continuous Glucose Monitoring in Type 1 Diabetes in the Netherlands.对《致编辑的信》的回应：关于荷兰1型糖尿病中混合闭环系统与多次每日注射加间歇性扫描式连续血糖监测的成本效益
Adv Ther. 2023 May;40(5):2545-2548. doi: 10.1007/s12325-023-02431-2. Epub 2023 Mar 9.

本文引用的文献

1
Safety and Glycemic Outcomes During the MiniMed Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.安全性和血糖控制效果：MiniMed 先进型混合闭环系统在儿童和青少年 1 型糖尿病患者中的关键性试验
Diabetes Technol Ther. 2023 Nov;25(11):755-764. doi: 10.1089/dia.2023.0255. Epub 2023 Oct 25.
2
Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.1型糖尿病中间歇性扫描式连续血糖监测与先进混合闭环系统的成本效益：对Jendle等人研究的评论
Diabetes Ther. 2022 May;13(5):1121-1123. doi: 10.1007/s13300-022-01251-x. Epub 2022 Apr 11.
3
Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users.真实世界中 MiniMed™ 780G 系统的性能：来自 4120 名使用者结果的首次报告。
Diabetes Technol Ther. 2022 Feb;24(2):113-119. doi: 10.1089/dia.2021.0203.
4
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.比较实时和间歇性扫描连续血糖监测在 1 型糖尿病成人患者中的应用（ALERTT1）：一项 6 个月前瞻性多中心随机对照试验。
Lancet. 2021 Jun 12;397(10291):2275-2283. doi: 10.1016/S0140-6736(21)00789-3. Epub 2021 Jun 2.
5
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspend in People With Type 1 Diabetes.美敦力 MiniMed 先进混合闭环输送可改善血糖控制效果：一项比较预测性低血糖暂停的自动胰岛素输送与 1 型糖尿病患者的随机交叉试验结果。
Diabetes Care. 2021 Apr;44(4):969-975. doi: 10.2337/dc20-2250. Epub 2021 Feb 12.
6
Change in Hemoglobin A1c and Quality of Life with Real-Time Continuous Glucose Monitoring Use by People with Insulin-Treated Diabetes in the Landmark Study.在 landmark 研究中，使用实时连续血糖监测的胰岛素治疗糖尿病患者的糖化血红蛋白变化和生活质量。
Diabetes Technol Ther. 2021 Mar;23(S1):S35-S39. doi: 10.1089/dia.2020.0666.
7
Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres.使用动态葡萄糖监测改善1型或2型糖尿病患者的糖化血红蛋白控制：德国两个中心的回顾性观察分析
Diabetes Ther. 2021 Jan;12(1):363-372. doi: 10.1007/s13300-020-00978-9. Epub 2020 Dec 11.
8
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial.《1 型糖尿病成人患者经皮指尖血糖监测的混合闭环与手动胰岛素输注 6 个月的随机对照试验》
Diabetes Care. 2020 Dec;43(12):3024-3033. doi: 10.2337/dc20-1447. Epub 2020 Oct 14.
9
One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.1 型糖尿病患儿和青少年使用混合闭环系统治疗 1 年的经验：取得成功的驱动因素。
Acta Diabetol. 2021 Feb;58(2):207-213. doi: 10.1007/s00592-020-01607-4. Epub 2020 Oct 12.
10
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study.1 型糖尿病患者接受间歇性扫描连续血糖监测 1 年后的生活质量和血糖控制（FUTURE）：一项前瞻性观察性真实世界队列研究。
Diabetes Care. 2020 Feb;43(2):389-397. doi: 10.2337/dc19-1610. Epub 2019 Dec 16.